ITGR Stock Recent News

Integer Holdings Corporation ITGR wrapped up 2024 with a solid top-line performance. Fourth-quarter revenues of $449.5 million increased 8.8% year over year and outpaced expectations.

Integer Holdings' fourth-quarter results reflect robust sales from the majority of the product lines, along with continued product adoption.

Integer Holdings Corporation (NYSE:ITGR ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Andrew Senn – Senior Vice President-Strategy, Business Development and Investor Relations Joe Dziedzic – President and Chief Executive Officer Diron Smith – Executive Vice President and Chief Financial Officer Conference Call Participants Brett Fishbin – KeyBanc Capital Markets Craig Bijou – Bank of America Matthew O'Brien – Piper Sandler Richard Newitter – Truist Securities Nathan Treybeck – Wells Fargo Suraj Kalia – Oppenheimer Operator Hello and welcome to the Integer Holdings Corporation Fourth Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.

Integer (ITGR) came out with quarterly earnings of $1.43 per share, missing the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.39 per share a year ago.

~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations.

Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.

PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences. Integer will participate at the 2025 Raymond James & Associates' 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida.

Get a deeper insight into the potential performance of Integer (ITGR) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?